Patents by Inventor Sameer Pralhad KAWATKAR

Sameer Pralhad KAWATKAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • JAK1 selective inhibitors
    Patent number: 11897869
    Abstract: Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1-R8 have any of the meanings defined herein. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of using the same.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: February 13, 2024
    Assignee: AstaZeneca AB
    Inventors: Karl Magnus Nilsson, Annika Birgitta Margareta Åstrand, Anna Ingrid Kristina Berggren, Johan R. Johansson, Matti Juhani Lepistö, Sameer Pralhad Kawatkar, Qibin Su, Jason Grant Kettle
  • JAK1 SELECTIVE INHIBITORS
    Publication number: 20210188821
    Abstract: Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1-R8 have any of the meanings defined herein. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of using the same.
    Type: Application
    Filed: March 1, 2021
    Publication date: June 24, 2021
    Inventors: Karl Magnus NILSSON, Annika Birgitta Margareta ÅSTRAND, Anna Ingrid Kristina BERGGREN, Johan R. JOHANSSON, Matti Juhani LEPISTÖ, Sameer Pralhad KAWATKAR, Qibin SU, Jason Grant KETTLE
  • JAK1 selective inhibitors
    Patent number: 10961228
    Abstract: Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1-R8 have any of the meanings defined herein. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of using the same.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: March 30, 2021
    Assignee: ASTRAZENECA AB
    Inventors: Karl Magnus Nilsson, Annika Birgitta Margareta Astrand, Anna Ingrid Kristina Berggren, Johan R. Johansson, Matti Juhani Lepisto, Sameer Pralhad Kawatkar, Qibin Su, Jason Grant Kettle
  • JAK1 SELECTIVE INHIBITORS
    Publication number: 20190367490
    Abstract: Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1-R8 have any of the meanings defined herein. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of using the same.
    Type: Application
    Filed: January 16, 2018
    Publication date: December 5, 2019
    Applicant: AstraZeneca AB
    Inventors: Karl Magnus NILSSON, Annika Birgitta Margareta ASTRAND, Anna Ingrid Kristina BERGGREN, Johan R. JOHANSSON, Matti Juhani LEPISTO, Sameer Pralhad KAWATKAR, Qibin SU, Jason Grant KETTLE